✦ LIBER ✦

Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia

✍ Scribed by Stephen J. Lauer; Donald Pinkel; George R. Buchanan; Peggy Sartain; Joann M. Cornet; Robert Krance; Luis D. Borella; James T. Casper; Larry E. Kun; Raymond G. Hoffman; Bruce M. Camitta

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 509 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19871115)60:10<2366::aid-cncr2820601003>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study of intermediate-dose metho

A pilot study of intermediate-dose methotrexate and cytosine arabinoside, “Spread-out” or “Up-front,” in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia a pediatric oncology group study

✍ Robert A. Krance; Edward M. Newman; Donald Pinkel; Yaddanapudi Ravindranath; Mic 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

One hundred six children with newly diagnosed non-T-, non-B-cell acute lymphoblastic leukemia (ALL) were treated in a Pediatric Oncology Group (POG) pilot study in which six courses of intermediate-dose methotrexate (MTX) and cytosine arabinoside (Ara-C) (1 g/m2 each) were added to a "backbone" of s